Pay in installments of $5.88 with
,
and
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jun 17 - Jun 22
For Your Every Summer RSVP, with Code: SUMMER15
Description
Leukomed Dressings | Non Woven Wound Dressing | 10 x 25cm | Pack of 50The BSN Leukomed Sterile Adhesive Dressing is a gentle and highly absorbent non woven post op dressing that is exceptionally comfortable, and its rounded edges prevent the dressing from peeling. The BSN Leukomed Sterile Adhesive Dressing is air and moisture permeable, making them particularly good for the skin friendly treatment of exuding wounds. The BSN Leukomed Sterile Adhesive Dressing is composed of an acrylic adhesive and non woven substrate

Shipping Notes
- Free Standard Shipping on $100+ Orders to the USA.
- Except Preorder products are shipped in 48 hours.
- Delivery to the USA:
- Standard Shipping : 3-10 business days
- If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
4.1 ★★★★★
Based on 1196 reviews
Sort
Product Reviews
★★★★★ 5
Works fine
Style: Ink
A+ ink, expensive but needed for my job.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on April 2, 2026
★★★★★ 5
Great product!!
Style: Ink
Great price!!
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on March 13, 2026
★★★★★ 5
Great product
Style: Ink
Great product
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on March 17, 2026
★★★★★ 5
Works great
Style: Ink
No issues
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 11, 2026
★★★★★ 5
Good price
Style: Ink
Did not include the black cartridge. I should have payed more attention to description
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on February 9, 2026




